SD Biosensor stock gained 1.42 percent on October 6

Published on 10/07/2026 at 00:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

SD Biosensor stock's market capitalization reached KRW 769.2 billion on October 6, 2026, while the 52-week range was KRW 5,800 to KRW 10,190. First-half profit reached KRW 38.6 billion.

SD Biosensor, KR7137310009, Illustration mit AI erstellt.

SD Biosensor stock (ISIN KR7137310009) was last at KRW 6,430 on the Korea Exchange on October 6, 2026 at 3:30 p.m. KST, up 1.42 percent for the session. The latest half-year figures show a business moving toward profitability as overseas subsidiaries and equipment-based diagnostic platforms gain weight.

Half-year sales improve

According to Seoul Economic Daily on September 14, 2026, SD Biosensor's first-half revenue rose 8 percent to KRW 380 billion. The operating loss narrowed to KRW 18.9 billion from KRW 35.1 billion, a reduction of KRW 16.2 billion, while net profit reached KRW 38.6 billion.

The quarterly trend also improved year over year. ATS View reports that second-quarter revenue was KRW 186 billion in 2026, up 12.0 percent from the prior-year quarter, while the operating loss stood at KRW 7.3 billion and the operating margin was negative 3.9 percent.

Standard M10 drives expansion

The revenue mix provides the clearest operating signal. Seoul Economic Daily reported that first-half revenue from the Standard M10 point-of-care molecular diagnostics platform rose 87 percent to KRW 22 billion, while the Indian unit grew 31 percent to KRW 45.9 billion.

That combination matters because SD Biosensor is using the same platform across tuberculosis, respiratory illness and sexually transmitted infection testing. The company also said on its official website on September 30, 2026, that it had been listed in the World Health Organization's official recommendation for latent tuberculosis testing.

Stock remains below yearly high

SD Biosensor's October 6, 2026 session included a volume of 138,609 shares and left the stock between its 52-week low of KRW 5,800 and high of KRW 10,190. The market capitalization was KRW 769.2 billion on the same date, giving the improving earnings trend a small-cap market setting.

For investors, the key test is whether overseas growth can convert into recurring operating profit. The latest quarter still carried a KRW 7.3 billion operating loss, even as first-half net profit reached KRW 38.6 billion.